Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians
Bush To Propose Increase for Cancer Screening, FDA Generics Reviews
FASEB Urges 10% Increase for NIH in FY04
NCI Supports New Cervical Cancer Screening Guideline
Hugh Creech, Fox Chase Chemotherapy Pioneer, Dead at 92
(8-page issue).
Includes January Business & Regulatory Report (8-page issue).
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









